Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy.

作者信息

Kumarasamy N, Vallabhaneni Snigdha, Cecelia Anitha J, Mayer Kenneth H, Solomon Suniti, Carpenter Charles C J, Flanigan Timothy P

出版信息

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):377-8. doi: 10.1097/01.qai.0000176591.06549.de.

DOI:10.1097/01.qai.0000176591.06549.de

PMID:16249715

Abstract

摘要

相似文献

Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy.

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):377-8. doi: 10.1097/01.qai.0000176591.06549.de.

Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.

Pediatr Infect Dis J. 2005 Dec;24(12):1117-20. doi: 10.1097/01.inf.0000190038.53813.d2.

Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.

Arch Intern Med. 2002 Apr 22;162(8):921-8. doi: 10.1001/archinte.162.8.921.

Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.

AIDS. 2001 Sep 28;15(14):1912-3. doi: 10.1097/00002030-200109280-00034.

Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis.

AIDS. 2002 Jul 5;16(10):1433-4. doi: 10.1097/00002030-200207050-00021.

A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.

N Engl J Med. 2001 Jan 18;344(3):159-67. doi: 10.1056/NEJM200101183440301.

Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.

J Infect Dis. 2000 May;181(5):1635-42. doi: 10.1086/315471. Epub 2000 May 15.

From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.

JAMA. 1991 Apr 3;265(13):1637-40, 1643-4.

Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):104-14. doi: 10.1097/00042560-199706010-00002.

Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?

Thorax. 2000 Aug;55 Suppl 1(Suppl 1):S15-22. doi: 10.1136/thorax.55.suppl_1.s15.

引用本文的文献

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design.

Contemp Clin Trials. 2015 Jul;43:100-4. doi: 10.1016/j.cct.2015.05.015. Epub 2015 May 22.

Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.

Clin Infect Dis. 2014 Aug 1;59(3):435-45. doi: 10.1093/cid/ciu283. Epub 2014 Apr 23.

Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy.

BMC Infect Dis. 2010 May 21;10:126. doi: 10.1186/1471-2334-10-126.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验